Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electronic cigarettes: can dependable public health policies be developed and applied without relevant and reliable risk assessments?

Alternatives to laboratory animals : ATLA·2018
Same author

The replacement of animal tests.

Alternatives to laboratory animals : ATLA·2018
Same author

The use of in vivo, ex vivo, in vitro, computational models and volunteer studies in vision research and therapy, and their contribution to the Three Rs.

Alternatives to laboratory animals : ATLA·2016
Same author

A critical assessment of the scientific basis, and implementation, of regulations for the safety assessment and marketing of innovative tobacco-related products.

Alternatives to laboratory animals : ATLA·2015
Same author

The Three Rs--opportunities for improving animal welfare and the quality of scientific research.

Alternatives to laboratory animals : ATLA·2014
Same author

Every silver lining has a cloud: the scientific and animal welfare issues surrounding a new approach to the production of transgenic animals.

Alternatives to laboratory animals : ATLA·2014
Same journal

Mammalian Respiratory Chain Complex Assemblies and Their Links to Mitochondria Stress-Induced Human Diseases.

Advances in experimental medicine and biology·2026
Same journal

Enzyme Assemblies in Nucleotide Metabolism: Structure, Regulation, and Disease Implications.

Advances in experimental medicine and biology·2026
Same journal

The Pyruvate Dehydrogenase Complex: A 90-Year-Old Enigma Shaping the Future of Structural Enzymology.

Advances in experimental medicine and biology·2026
Same journal

Regulation of the Anti-termination RNA Transcription Complex by Lon-Mediated Lambda N Degradation.

Advances in experimental medicine and biology·2026
Same journal

PCNA Macromolecular Complexes: PCNA Serves as a Molecular Hub Regulating Multiple Cellular Processes Inside and Outside of the Nucleus.

Advances in experimental medicine and biology·2026
Same journal

Dynamic Assemblies in Genome Maintenance.

Advances in experimental medicine and biology·2026
See all related articles

Related Experiment Video

Updated: May 23, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

In silico methods for toxicity prediction.

Robert D Combes1

  • 1robert_combes3@yahoo.co.uk

Advances in Experimental Medicine and Biology
|March 23, 2012
PubMed
Summary
This summary is machine-generated.

Quantitative Structure-Activity Relationship ((Q)SAR) models and expert systems aid in predicting chemical toxicity and biotransformation. Further development and validation are needed for their full regulatory potential in chemical risk assessment.

More Related Videos

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

Related Experiment Videos

Last Updated: May 23, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

Area of Science:

  • Computational toxicology
  • In silico modeling
  • Chemical risk assessment

Background:

  • Quantitative Structure-Activity Relationship ((Q)SAR) models and expert systems are computational tools used to predict the toxicological properties and metabolic fate of foreign chemicals (xenobiotics).
  • These methods offer potential alternatives to traditional animal testing, aligning with the principles of the 3Rs (Replacement, Reduction, Refinement).

Purpose of the Study:

  • To describe the principles and applications of (Q)SAR models and expert systems for predicting toxicity and biotransformation.
  • To discuss the advantages, disadvantages, validation, and regulatory acceptance of these in silico methods.
  • To explore their potential use in regulatory toxicity testing and integrated testing strategies for chemical risk assessment.

Main Methods:

  • Review and illustration of (Q)SAR models and expert systems using published literature for key toxicity endpoints.
  • Discussion of validation requirements and acceptance criteria for regulatory use.
  • Consideration of application within decision-tree testing schemes and read-across approaches.

Main Results:

  • Significant progress has been made in the development and application of in silico approaches for toxicity prediction.
  • Examples from literature demonstrate the utility of these models for specific toxicity endpoints and biotransformation prediction.
  • Challenges remain in achieving widespread regulatory acceptance and fulfilling the full potential of these methods.

Conclusions:

  • In silico methods show promise for regulatory toxicity testing, but require further development and validation.
  • Wider availability of biological data and international consensus on validation are crucial.
  • Mechanistic understanding underlying structure-activity relationships is essential for enhancing model predictivity for novel chemicals.